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Henipaviruses  
and Fruit Bats,  
Papua New Guinea
To the Editor: In 2010, detection 
of henipavirus (Hendra or Nipah virus) 
and rubulavirus (Tioman or Menangle 
virus) antibodies in fruit bats in Papua 
New Guinea (PNG) was reported (1). 
To explore changes in henipavirus dy-
namics in fruit bats, we compare and 
contrast this finding with serologic 
findings from 10 years earlier (2; H. 
Field et al., unpub. data).
In these earlier studies, blood 
samples were collected from 182 
wild-caught fruit bats of mixed spe-
cies, age, and sex from 3 locations in 
PNG: Madang (1996), New Britain 
(1997), and Lae (1999 ) (2; H. Field 
et al., unpub. data) (Figure). The 20 
samples from Madang were collected 
as blood spots on filter paper and for-
warded to the (then) Department of 
Primary Industries Animal Research 
Institute in Brisbane, Australia, where 
they were eluted and screened by 
ELISA for antibodies against Hen-
dra virus (3). Serum from 59 samples 
from New Britain and 103 from Lae 
were forwarded to the Common-
wealth Scientific and Industrial Re-
search Organisation’s Australian Ani-
mal Health Laboratory in Geelong, 
Australia. Samples from New Britain 
were screened for antibodies against 
Hendra virus by virus neutralization 
test (VNT) (3). Positive samples were 
subsequently screened by VNT for an-
tibodies against Nipah virus. Samples 
from Lae were screened by VNT for 
Hendra, Nipah, and Menangle viruses 
(3). A reciprocal VNT titer of >5 was 
considered indicative of antibodies.
Of the 20 samples from Madang, 
2 (10%) reacted in the Hendra virus 
ELISA. Of the 147 samples from 
New Britain and Lae that yielded 
definitive VNT results, 11 (7.5%) 
yielded neutralizing antibodies to 
Hendra virus and 5 (3.4%) to Nipah 
virus. All samples with antibodies 
against Nipah virus also had anti-
bodies against Hendra virus; titers 
against Hendra virus were greater (4 
samples) or equivalent (1 sample) to 
those against Nipah virus. Recipro-
cal titers against Hendra virus were 










virus, 5–80 (median 10). None of the 
103 samples from Lae had antibodies 
against Menangle virus (Figure).
The common and contrasting find-
ings between the study of Breed et al. 
(1) and the earlier studies are as fol-
lows. First, the earlier studies identified 
antibodies against Hendra virus in fruit 
bats from multiple locations and spe-
cies, as did the study by Breed et al. (1). 
However, in marked contrast, the ear-
lier studies found a crude prevalence 
of antibodies against Hendra virus of 
7.8% (13/167) compared with 50% 
found by Breed et al. (1). Although this 
difference could reflect confounding 
by species, location, or time, when we 
controlled for the first 2 by comparing 
only 1 bat species (Pteropus conspicil-
latus) from proximate locations (Lae 
and Madang), the significant differ-
ences in antibody prevalence remained: 
0 (95% CI 0–23%) in 1999 and 65% 
(95% CI 50%–78%) in 2009.
Second, in the earlier studies, all 
bats (except 1) that had a neutraliz-
ing antibody titer to Nipah virus had 
a higher neutralizing titer to Hendra 
virus (1 bat had equivalent titers), sug-
gesting that the circulating henipavi-
rus was more similar to Hendra virus 
than to Nipah virus. These findings are 
supported at a regional level by those 
reported for nearby Indonesian islands 
by Sendow et al. (4). However, the 
more recent findings of Breed et al. (1) 
suggest the opposite. Of note, in the 
earlier PNG studies, titers against Hen-
dra and Nipah viruses were modest 
(median 10) and pose the possibility of 
cross-neutralization by a related, but 
undescribed, additional henipavirus.
Third, the earlier studies found no 
antibodies against Menangle virus in 
the 103 samples; in contrast, Breed et 
al. found 56% (1). Thus, earlier stud-
ies found no samples with antibodies 
against Menangle virus and henipavi-
rus, in contrast to 36% of samples re-
ported by Breed et al. (1).
Although any of these differences 
might have multiple interpretations, 
the collective scope and magnitude of 
the differences is more consistent with 
a major 10-year change in infection 
dynamics in these bat populations. 
Sendow et al. (4), when reporting 
henipavirus infections in fruit bats in 
Indonesia, canvassed the geographic 
extent of Hendra virus and Nipah vi-
rus, concluding that a transition prob-
ably occurred between Hendra virus in 
Australia and Nipah virus in Malaysia 
and beyond. They also concluded that 
further research was needed to under-
stand the nature and stability of the 
interface between Hendra virus and 
Nipah virus and to investigate the pos-
sible presence of unidentified cross-
neutralizing henipaviruses.
Changed henipavirus dynamics 
in PNG fruit bat populations could 
reflect altered population dynamics 
(and consequent infection dynamics) 
associated with negative ecologic ef-
fects (e.g., habitat loss, encroachment) 
(5). More broadly, such changes might 
portend a regional shift in the geo-
graphic interface between Hendra and 
Nipah virus endemicity.
More robust interpretation of the 
serologic findings of both studies is 
constrained by the lack of henipavirus 
sequence data from PNG and neigh-
boring countries. We concur with 
Breed et al. (1) that sequencing and 
phylogenetic analyses are imperative 
if the ecology of henipaviruses in fruit 
bat populations and the implications 
for human and livestock health in the 
region are to be fully understood.
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